Caricamento...
Antibody-drug conjugates—an emerging class of cancer treatment
Antibody-drug conjugates (ADCs) are an emerging novel class of anticancer treatment agents that combines the selectivity of targeted treatment with the cytotoxic potency of chemotherapy drugs. New linker technology associated with novel highly potent cytotoxic payloads has permitted the development...
Salvato in:
| Pubblicato in: | Br J Cancer |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Nature Publishing Group
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4815767/ https://ncbi.nlm.nih.gov/pubmed/26742008 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2015.435 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|